Gastric HER2 Testing Study (GaTHER): an evaluation of gastric/gastroesophageal junction cancer testing accuracy in Australia.
Fox, Stephen B; Kumarasinghe, Marian Priyanthi; Armes, Jane E; Bilous, Michael; Cummings, Margaret C; Farshid, Gelareh; Fitzpatrick, Nicole; Francis, Glenn D; McCloud, Philip I; Raymond, Wendy; Morey, Adrienne.
Am J Surg Pathol
; 36(4): 577-82, 2012 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-22314190
HER2/HER3 pathway in biliary tract malignancies; systematic review and meta-analysis: a potential therapeutic target?
The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells.
A novel gene-protein assay for evaluating HER2 status in gastric cancer: simultaneous analyses of HER2 protein overexpression and gene amplification reveal intratumoral heterogeneity.
Mass-spectrometry-based quantitation of Her2 in gastroesophageal tumor tissue: comparison to IHC and FISH.
In vivo evidence supporting a metastasis suppressor role for Stard13 (Dlc2) in ErbB2 (Neu) oncogene induced mouse mammary tumors.
Targeting CXCR1/2 significantly reduces breast cancer stem cell activity and increases the efficacy of inhibiting HER2 via HER2-dependent and -independent mechanisms.
Purification and immunodetection of the complete recombinant HER-2[neu] receptor produced in yeast.
ß-Catenin haploinsufficiency promotes mammary tumorigenesis in an ErbB2-positive basal breast cancer model.
Expression of full-length HER2 protein in Sf9 insect cells and its presentation on the surface of budded virus-like particles.
HER2 testing in paired biopsy and excision specimens of gastric cancer: the reliability of the scoring system and the clinicopathological factors relevant to discordance.